Fukuda, Keiji

Director and Clinical Professor
Division of Community Medicine and Public Health Practice
Contact Information
Tel: 3917 6828
Email: This email address is being protected from spambots. You need JavaScript enabled to view it.


Professor Keiji Fukuda joined the School of Public Health of The University of Hong Kong in December 2016. Professor Fukuda has extensive public health experience at global and national levels. During 2005 – 2016, he was a staff member of the World Health Organization (WHO) and held positions as Scientist, Coordinator and then Director of the Global Influenza Programme (2005-2008), Assistant Director-General for Health Security and Environment ad interim (2008-2009), Special Adviser on Pandemic Influenza to the Director-General (2009-2010), Assistant Director-General for Health Security (2010-2015) and Special Representative for Antimicrobial Resistance for the Director-General (2015-2016).

At WHO, he was instrumental in global and national approaches to issues such as health security; preparedness and responses for emerging infectious diseases; the development and adoption of the Pandemic Influenza Preparedness Framework, a ground breaking intergovernmental agreement on the sharing of potential pandemic influenza viruses and related benefits; and implementation of the International Health Regulations. He personally led several field investigations related to globally important and sensitive outbreaks such as influenza H5N1 and H7N9, Pandemic influenza, SARS, MERS and Ebola and was often WHO’s main media spokesperson for such issues. Most recently, he directly facilitated the successful development of an intergovernmental, multisectoral process which resulted in a historic Heads of State level meeting at the United Nations (UN), and a UN resolution, on antimicrobial resistance. During his tenure at WHO, Professor Fukuda has become increasingly involved and interested in health diplomacy, which has emerged as a major need in an increasingly globalized world.

Before joining WHO, Professor Fukuda was Chief of Epidemiology in the Influenza Branch of the U.S. Centers for Disease Control and Prevention Centers (CDC). He led the CDC field teams that assisted Hong Kong during the emergence of avian influenza H5N1 in 1997 and has worked closely and extensively with China on issues such as influenza surveillance, SARS and influenza H7N9. He helped develop new models combining epidemiological and laboratory data to estimate the burden of influenza and on US influenza vaccination policy. Early in his career, Professor Fukuda worked on chronic fatigue syndrome and led the international team that redefined this condition. He is a physician who trained in internal medicine and received his BA from Oberlin College, MD from the University of Vermont and MPH from the University of California, Berkeley.

HKU Scholars Hub: Fukuda, Keiji

Open Research and Contributor ID (ORCID): Fukuda, Keiji


Selected Publications  (Pub Med Search)

  1. Hu Y.J., Cowling B.J. and Fukuda K., What is missing in surveillance for control of antimicrobial resistance?, The Lancet Infectious Diseases. 2018, 18: 597-598.
  2. Fukuda K., Limmathurotsakul D., Okeke I.N., Shetty N., van Doorn R., Feasey N.A., Chiara F., Zoubiane G., Jinks T., Parkhill J., Patel J., Reid S.W.J., Holmes A.H. and Peacock S.J., Surveillance and Epidemiology of Drug Resistant Infections Consortium (SEDRIC): Supporting the transition from strategy to action. Wellcome Open Research. 2018, 3: 59.
  3. Keiji Fukuda. World leaders gather at UN to tackle global problem of antibiotic resistance. Global Health and Diplomacy 2016; Fall:13-14.
  4. Marc Sprenger and Keiji Fukuda. New mechanisms, new worries. Science 2016;351:1263-64.
  5. Keiji Fukuda and Marie Paule Kieny. Different Approaches to Influenza Vaccination. New England Journal of Medicine 2006; 355:2586-2587.
  6. William W.  Thompson, David K. Shay, Eric Weintraub, Lynnette Brammer, Nancy Cox, Larry J. Anderson, Keiji Fukuda. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003;289:179-186.
  7. Izurieta H.S., Thompson W.W., Kramarz P., Shay D.K., Davis R.L., DeStefano F., Black S., Shinefield H., Fukuda K. Influenza and the rates of hospitalization for respiratory disease among infants and young children. New England Journal of Medicine 2000;342-232-9.
  8. Mounts A.W., Kwong H., Izurieta H.S., Ho Y.Y., Au T.K., Lee M., Bridges C.B., Williams S.W., Mak K.H., Katz J., Thompson W.W., Cox N.J., Fukuda K. Case-control study of risk factors for avian influenza A(H5N1) diseases, Hong Kong, 1997. Journal of Infectious Diseases 1999;180:505-8.
  9. Meltzer M., Cox N.J., Fukuda K. The economic impact of pandemic influenza in the United States: Priorities for intervention. Emerging Infectious Diseases 1999;5:1-13
  10. Fukuda K., Nisenbaum R., Stewart G., Thompson W.W., Robin L., Washko R.M., Noah D.L., Barrett D.H., Randall B., Herwaldt B.L., Mawle A.C., Reeves W.C. A chronic multisymptom illness affecting Air Force Veterans of the Gulf War.  Journal of the American Medical Association 1998;280:961-989.
  11. Simenson L., Clarke M.J., Schonberger L.B., Arden N.H., Cox N.J., Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. Journal of Infectious Diseases. 1998;178:53-60.
  12. Fukuda K., Straus S.E., Hickie I., Sharpe M.C., Dobbins J.G., Komaroff A. and the international CFS study group. The Chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals of Internal Medicine 1994;121:953-959.


BIGtheme.net Joomla 3.3 Templates